CVE-2012-6348

Description

Centrify Deployment Manager 2.1.0.283, as distributed in Centrify Suite before 2012.5, allows local users to (1) overwrite arbitrary files via a symlink attack on the adcheckDMoutput temporary file, or (2) overwrite arbitrary files and consequently gain privileges via a symlink attack on the centrify.cmd.0 temporary file.

Category

3.3
CVSS
Severity: Low
CVSS 2.0 •
EPSS 0.05%
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://archives.neohapsis.com/archives/bugtraq/2012-12/0113.html mailing list
http://archives.neohapsis.com/archives/bugtraq/2012-12/0097.html mailing list
http://archives.neohapsis.com/archives/bugtraq/2012-12/0036.html mailing list
http://archives.neohapsis.com/archives/bugtraq/2012-12/0071.html mailing list
http://vapid.dhs.org/exploits/centrify_local_r00t.c
http://archives.neohapsis.com/archives/bugtraq/2012-12/0037.html mailing list
http://vapid.dhs.org/advisories/centrify_deployment_manager_insecure_tmp2.html

Frequently Asked Questions

What is the severity of CVE-2012-6348?
CVE-2012-6348 has been scored as a low severity vulnerability.
How to fix CVE-2012-6348?
To fix CVE-2012-6348, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-6348 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2012-6348 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.